Analysis Metabolite Name Measured Value Units Sample description Tissue
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline8.593uMWM47 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline9.888uMWM47 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.007uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.103uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.199uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.331uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.679uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.739uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.882uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline10.918uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.084uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.446uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.482uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.494uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.697uMWM47 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.889uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.973uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline11.985uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.105uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.225uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.225uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.545uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.584uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.651uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline12.824uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.184uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.184uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.303uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.303uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.502uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.663uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.714uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.783uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.783uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline13.927uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.022uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.022uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.022uMWM47 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.033uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.14uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.262uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.352uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.382uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.742uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.861uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline14.926uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.101uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.152uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.309uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.581uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.581uMWM47 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.581uMWM47 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.7uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.7uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline15.734uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.053uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.17uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.18uMWM47 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.3uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.419uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.539uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.585uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.622uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.867uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline16.904uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.187uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.329uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.413uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.498uMWM3311 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.527uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.648uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.738uMWM3311 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline17.858uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.073uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.073uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.092uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.205uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.286uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.318uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.318uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.544uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.577uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.657uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline18.996uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.176uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.181uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.223uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.349uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.449uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.562uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.562uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline19.562uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.014uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.048uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.127uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.127uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.306uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.353uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.412uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.627uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline20.919uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.205uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.369uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.369uMWM47 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.484uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.597uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.597uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.687uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.693uMWM3311 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.71uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.823uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.9uMWM47 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline21.936uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.072uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.163uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.326uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.361uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.412uMWM47 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.502uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.538uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.615uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline22.963uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.067uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.067uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.519uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.601uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.633uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.633uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.633uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.746uMWM3000 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline23.859uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline24uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline24.558uMWM47 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline24.763uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline24.876uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline24.989uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline25.102uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline25.668uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline26.024uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline26.346uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline26.799uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline26.912uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.084uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.084uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.216uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.251uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.322uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.477uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.641uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.816uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.854uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline27.929uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline28.048uMA375 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline28.385uMWM3311 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline28.834uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline29.286uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline29.494uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline29.512uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline29.739uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline29.852uMWM3000 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline30.53uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline30.756uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline31.208uMA375 CTRL plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline31.322uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline31.548uMWM3000 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline31.711uMA375 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline31.904uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline32.482uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.157uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.169uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.276uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.47uMA375 LCT-MCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.735uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.735uMA375 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline33.831uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline34.12uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline35.296uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline35.508uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline35.663uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline35.855uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline36.145uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline36.337uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline36.359uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline37.012uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline37.494uMA375 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline37.494uMA375 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline37.88uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline38.265uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline38.651uMWM3000 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline38.91uMWM3311 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline39.036uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline39.229uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline39.422uMWM3000 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline40.193uMA375 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline40.482uMA375 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline41.046uMA375 LCT plasma
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline41.462uMWM3311 LCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline41.542uMWM3000 CTRL tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline41.639uMA375 LCT-MCT tumor
Reversed phase POSITIVE ION MODEtrans-4-Hydroxyproline41.831uMWM3000 LCT-MCT tumor

Return to search page
  logo